Nanotheranostics in Pulmonary Infections: A Game-Changer for Respiratory Medicine
Nanotheranostics in Pulmonary Infections: A Game-Changer for Respiratory Medicine Pulmonary infections remain one of the most pressing global health challenges, particularly due to the increasing prevalence of antimicrobial resistance (AMR). As traditional treatments lose efficacy, the integration of nanotechnology into diagnosis and therapy — known as nanotheranostics — is emerging as a powerful strategy to revolutionize respiratory care. This article explores the role of nanotheranostics in diagnosing, treating, and preventing lower respiratory tract infections (LRTIs), with particular focus on drug delivery, rapid diagnostics, anti-biofilm strategies, and nanovaccine development. Introduction Pulmonary infections are responsible for substantial global morbidity and mortality, accounting for over 2.18 million deaths annually as of 2021....